FUNCTIONAL RESIDUAL CAPACITY INCREASED

This adverse event was reported 39 times

FUNCTIONAL RESIDUAL CAPACITY INCREASED is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DICLOFENAC SODIUM AND MISOPROSTOL 8 0.0012
1 CICLESONIDE 8 0.0006
2 FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE 27 0.0004
3 DESOXIMETASONE 8 0.0004
4 VORICONAZOLE 9 0.0003
5 TIOTROPIUM BROMIDE INHALATION SPRAY 3 0.0003
6 LORATADINE AND PSEUDOEPHEDRINE SULFATE 2 0.0003
7 OMALIZUMAB 18 0.0002
8 FLUOXETINE HCL 1 0.0002
9 GLYCOPYRROLATE 1 0.0002
See all drugs enriched for association with FUNCTIONAL RESIDUAL CAPACITY INCREASED

FUNCTIONAL RESIDUAL CAPACITY INCREASED is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-5 Antagonist [EPC] 5 0.0073
1 Prostaglandin E1 Analog [EPC] 8 0.0005
2 Anti-IgE [EPC] 18 0.0002
3 Fluoroquinolone Antibacterial [EPC] 10 0.0001
4 Histamine-1 Receptor Antagonist [EPC] 5 0.0001
5 Azole Antifungal [EPC] 9 0.0001
6 Provitamin D2 Compound [EPC] 1 0.0000
7 Thiazide Diuretic [EPC] 6 0.0000
8 Angiotensin 2 Receptor Blocker [EPC] 9 0.0000
9 Corticosteroid [EPC] 24 0.0000
See all drug classes enriched for association with FUNCTIONAL RESIDUAL CAPACITY INCREASED